4//SEC Filing
Boenisch Sandra 4
Accession 0001731122-25-000655
CIK 0001314052other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 8:00 PM ET
Size
5.7 KB
Accession
0001731122-25-000655
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-28+12,500→ 12,500 totalExercise: $8.57From: 2025-04-28Exp: 2033-03-31→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]On March 31, 2023, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was completion of enrollment of ANAVEX3-71 Phase 2 clinical trial in Schizophrenia. The performance criteria for this milestone was met, resulting in vesting of the option as to 12,500 shares.
Documents
Issuer
ANAVEX LIFE SCIENCES CORP.
CIK 0001314052
Entity typeother
Related Parties
1- filerCIK 0001655366
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 8:00 PM ET
- Size
- 5.7 KB